贝叶斯网络结构学习算法用于高度缺失和不可归因的数据:应用于乳腺癌放射治疗数据
Mélanie Piot1, Frédéric Bertrand2, Sébastien Guihard3
1University of Technology of Troyes, Troyes, 10004 CEDEX, France; Strasbourg Cancer Institute (ICANS), Strasbourg, 67200, France.
Artificial intelligence in medicine
|January 6, 2024
概括
本研究介绍了一种新的算法,用于从缺失值的医疗保健数据中学习贝叶斯网络图形. 该方法避免了归算和完整的案例分析,为复杂的数据集提供了可行的解决方案.
科学领域:
- 计算统计学 计算统计学
- 医疗保健中的机器学习
- 数据挖掘 数据挖掘
背景情况:
- 医疗保健数据经常显示出高比例的缺失值,这给分析带来了挑战.
- 传统的方法,如归算或完整的病例分析,往往不适合或导致显著的数据丢失在临床环境中.
- 对于贝叶斯网络而言,现有的结构学习算法可能会与大量缺失的数据作斗争.
研究的目的:
- 开发一种用于学习贝叶斯网络 (BN) 图形的新算法,可以处理缺少数据的数据集,而无需使用归算或完整的案例分析.
- 为从数据完整性受到损害的复杂医疗数据集中提取洞察力的强大方法.
- 评估拟议的算法的性能与现有的结构学习方法相比.
主要方法:
- 拟议的算法采用在完整的子数据集上使用本地引导学习的策略.
- 然后将这些本地学习的模型汇总和优化,形成最终的贝叶斯网络图.
- 这种方法绕过了直接归算或丢弃不完整记录的需要.
主要成果:
- 与其他已建立的结构学习算法相比,开发的学习方法表现出具有竞争力的性能.
- 该算法的有效性在各种缺失数据机制中是一致的.
- 它成功地学习贝叶斯网络结构,即使归算和完整的案例分析是不可行的.
结论:
- 拟议的算法为从不完整的医疗保健数据中学习贝叶斯网络提供了一个有价值的替代方案.
- 它有效地解决了归算和完整案例分析的局限性,保持了数据的实用性.
- 这种方法提高了贝叶斯网络在现实世界临床数据分析中的应用性.
更多相关视频
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
7.2K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.3K
相关概念视频
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Kaplan-Meier Approach
148
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
148
